Growth Metrics

Merck (MRK) Non-Current Deferred Tax Liability (2016 - 2025)

Merck (MRK) has disclosed Non-Current Deferred Tax Liability for 17 consecutive years, with $5.6 billion as the latest value for Q4 2025.

  • Quarterly Non-Current Deferred Tax Liability rose 82.17% to $5.6 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.6 billion through Dec 2025, up 82.17% year-over-year, with the annual reading at $5.6 billion for FY2025, 82.17% up from the prior year.
  • Non-Current Deferred Tax Liability for Q4 2025 was $5.6 billion at Merck, up from $1.4 billion in the prior quarter.
  • The five-year high for Non-Current Deferred Tax Liability was $5.6 billion in Q4 2025, with the low at $864.0 million in Q3 2024.
  • Average Non-Current Deferred Tax Liability over 5 years is $2.1 billion, with a median of $1.4 billion recorded in 2023.
  • The sharpest move saw Non-Current Deferred Tax Liability tumbled 79.78% in 2023, then surged 250.86% in 2024.
  • Over 5 years, Non-Current Deferred Tax Liability stood at $5.0 billion in 2021, then dropped by 14.19% to $4.3 billion in 2022, then crashed by 79.78% to $871.0 million in 2023, then soared by 250.86% to $3.1 billion in 2024, then surged by 82.17% to $5.6 billion in 2025.
  • According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods came in at $5.6 billion, $1.4 billion, and $1.4 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.